Abdulwasiu Ibrahim | Drug Discovery | Young Scientist Award

Posted on by ScienceFather

Mr. Abdulwasiu Ibrahim | Drug Discovery | Young Scientist Award

Research Fellow, Drosophila Research and Training Centre Nigeria

Abdulwasiu Ibrahim is a biochemist specializing in cancer biology, molecular biology, and bioinformatics. He is affiliated with the Department of Biochemistry, University of Ibadan, Nigeria. His expertise spans drug discovery, precision medicine, pharmacogenomics, and toxicogenomics. Proficient in computational biology, he applies computer-aided drug design, immunoinformatics, and biochemical analytics to research. His technical skills include gel electrophoresis, ELISA, PCR, and spectroscopy. He has a strong background in statistical analysis using GraphPad Prism and Microsoft Excel, with foundational knowledge of Python. He has extensive research experience in genetic profiling and biological drug delivery. Currently, he is a Research Fellow at the Drosophila Research and Training Centre and a Research Associate at the Institute of Bioinformatics and Molecular Therapeutics. He has received multiple conference fellowships and published several high-impact research papers. His work contributes to advancing cancer treatment and precision medicine using bioinformatics and molecular biology approaches.

Publication Profile

Oricd

šŸŽ“ Education

Master of Science in Biochemistry (Cancer Research and Molecular Biology) ā€“ University of Ibadan, Nigeria (2022ā€“2024) Thesis: Interactive Toxicity of 2-Acetylaminoflourene and Diethylnitrosamine in Drosophila melanogaster. Bachelor of Science in Biochemistry (Second Class Upper-Honours) ā€“ Usmanu Danfodiyo University, Sokoto, Nigeria (2015ā€“2019)
Thesis: Analgesic Activity of n-Hexane Extract of Castor Seed on Formalin-Induced Pain in Albino Rats.

šŸ’¼ Experience

Research Fellow ā€“ Drosophila Research and Training Centre (2022ā€“Present) Designed and conducted Drosophila experiments, supervised students, and managed lab operations.. Research Associate (Volunteer) ā€“ Institute of Bioinformatics and Molecular Therapeutics (2022ā€“Present) Developed computational models for drug discovery, performed molecular docking, and trained interns. Post-Graduate Research Assistant ā€“ University of Ibadan (2022ā€“2024) Conducted molecular analysis of cancer markers and supervised undergraduate projects. Research Assistant ā€“ Drosophila Laboratory, University of Ibadan (2021ā€“2022) Taught students Drosophila research techniques and performed oxidative stress biomarker analysis. Undergraduate Research Assistant ā€“ Usmanu Danfodiyo University (2019ā€“2020) Conducted phytochemical screening, biochemical analysis, and systematic reviews. Tutorial Teacher ā€“ Nigerian Society of Biochemistry Students (2019) Taught biochemistry, pharmacology, and molecular biology to undergraduate students.

šŸ† Awards & Honors

Conference Fellowships: 11th & 10th Conference of the Nigerian Institute of Medical Research (NIMR) (2022, 2021) 2nd Drug Discovery Africa International Conference (DDA) (2022) 2nd Conference of Nigerian Bioinformatics and Genomics Network (NBGN) (2021) 7th Unibadan Conference of Basic Medical Sciences (2021). Virtual Chair Award ā€“ Midwest Drosophila Conference (2022). Pre-Conference Workshops: Genotyping with TaqMan and Real-Time PCR Bioinformatics and Genome-Wide Association Studies Summer School: Hands-on training in bioinformatics and drug discovery. Best Paper Presentation: Nigerian Society of Biochemistry and Molecular Biology Conference (2021) Recognized for contributions to Drosophila biomedical research and computational drug design.

šŸ” Research Focus

Cancer Biology & Genomics: Investigating genetic markers and molecular pathways in cancer progression. Molecular Biology & Bioinformatics: Computational modeling of biomolecules and genome-wide association studies. Drug Discovery & Design: Using in silico techniques to identify potential drug candidates for cancer and neurodegenerative diseases. Precision Medicine & Genetic Profiling: Exploring personalized treatment approaches through pharmacogenomics. Pharmacogenomics & Toxicogenomics: Studying drug responses and toxic effects at the genetic level. Biological Drug Delivery: Developing targeted therapies using nanoformulations and bioactive compounds. Computational Biology: Expertise in homology modeling, molecular docking, virtual screening, and molecular dynamics simulations. Laboratory Techniques: Skilled in gel electrophoresis, ELISA, PCR, spectrophotometry, and tissue imaging.

Publication Top Notes

  • Computational Investigation of Polo-like Kinase 1 (PLK1): Inhibitive Potential of Benzimidazole-Carbonamide Derivatives for Cancer Treatment
    • Year: 2024
    • Authors: Ipinloju, N.; Balogun, T.A.; Ibrahim, A.; Adeyemo, M.A.; Esan, T.O.; Emmanuel, A.V.; Bello, K.A.; Omiyeniyi, G.D.; Oyeneyin, O.E.
    • Citation: Physical Chemistry Research
    • Link: DOI: 10.22036/pcr.2023.377616.2331

 

  • Identification of Phytochemicals with Inhibitory Potential Against Beta-lactamase Enzymes via Computer-aided Approach
    • Year: 2024
    • Authors: Nwokebu, G.C.; Adesina, A.B.; Isibor, C.N.; Aigbepue, S.A.; Egbo, C.C.; Pureaziba, N.; Isaac, O.O.; Owolade, A.J.-J.; Alabere, H.O.; Iwuagwu, M.O.
    • Citation: Bioorganic Chemistry
    • Link: DOI: 10.1016/j.bioorg.2024.107238

 

  • Insight into the Corrosion Inhibiting Potential and Anticancer Activity of 1-(4-methoxyphenyl)-5-methyl-Nā€™-(2-oxoindolin-3-ylidene)-1H-1,2,3-triazole-4-carbohydrazide via Computational Approaches
    • Year: 2024
    • Authors: Oluwatoba Emmanuel Oyeneyin; Abdulwasiu Ibrahim; Nureni Ipinloju; Adeniyi John Ademoyegun; Nathanael Damilare Ojo
    • Citation: Journal of Biomolecular Structure and Dynamics
    • Link: DOI: 10.1080/07391102.2023.2260491

 

  • Plant-derived Extracellular Vesicles as Potential Smart Nano Drug Delivery Systems for Antioxidant Vitamins C and E in Alzheimer’s Disease
    • Year: 2024
    • Authors: Amina Jiyah; Suleiman Alhaji Muhammad; Abdulwasiu Ibrahim; Ibrahim Bulama; Abdullahi Ibrahim; Abdullahi Yahya Abbas; Mustapha Umar Imam; Yusuf Saidu; Lawal Suleiman Bilbis
    • Citation: Journal of Drug Delivery Science and Technology
    • Link: DOI: 10.1016/j.jddst.2024.105618

 

  • Identification of Potential Acetylcholinesterase (AChE) Inhibitors from Vitis Vinifera: A Case Study of Alzheimerā€™s Disease (AD)
    • Year: 2023
    • Authors: Sofela, S.O.; Ibrahim, A.; Bodun, D.S.; Nwankwo, D.O.; Mafimisebi, M.; Abdulrasheed, B.; Balogun, T.; Opeyemi, I.
    • Citation: Research Square
    • Link: DOI: 10.21203/rs.3.rs-3342491/v1

 

  • Quantum Evaluation and Therapeutic Activity of (E)-N-(4-methoxyphenyl)-2-(4-(3-oxo-3-phenylprop-1-en-1-yl) phenoxy)acetamide and Its Modified Derivatives Against EGFR and VEGFR-2 in the Treatment of Triple-negative Cancer via In Silico Approach
    • Year: 2023
    • Authors: Ipinloju, N.; Ibrahim, A.; da Costa, R.A.; Adigun, T.B.; Olubode, S.O.; Abayomi, K.J.; Aiyelabegan, A.O.; Esan, T.O.; Muhammad, S.A.; Oyeneyin, O.E.
    • Citation: Journal of Molecular Modeling
    • Link: DOI: 10.1007/s00894-023-05543-2

 

  • Discovery of Potential Phytochemicals from Carica Papaya Targeting BRCA-1 in Breast Cancer Treatment
    • Year: 2023
    • Authors: Abdulwasiu Ibrahim; Nureni Ipinloju; Abdulsamad Omotayo Aiyelabegan; Abdulbaki Adio Alfa-Ibrahim; Suleiman Alhaji Muhammad; Oluwatoba Emmanuel Oyeneyin
    • Citation: Applied Biochemistry and Biotechnology
    • Link: DOI: 10.1007/s12010-023-04473-2

 

  • Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: An In Silico Repurposing Approach
    • Year: 2023
    • Authors: Abdulwasiu Ibrahim; Nureni Ipinloju; Nkechi Hope Atasie; Rahmotallah Mosunmola Babalola; Suleiman Alhaji Muhammad; Oluwatoba Emmanuel Oyeneyin
    • Citation: Applied Biochemistry and Biotechnology
    • Link: DOI: 10.1007/s12010-023-04376-2

 

  • Computational Evaluation of Azadirachta Indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer’s Disease
    • Year: 2023
    • Authors: Ishabiyi FO; Ogidi J; Olukade BA; Amorha CC; El-Sharkawy LY; Okolo CC; Adeniyi TM; Atasie NH; Ibrahim A.; Balogun TA
    • Citation: Journal of Alzheimer’s Disease (JAD)
    • Link: DOI: 10.3233/jad-221020

 

  • Discovery of Small Molecule PARKIN Activator as Therapeutics for PD: An In-silico Repurposing Approach
    • Year: 2022
    • Authors: Abdulwasiu Ibrahim; Nureni Ipinloju; Suleiman Alhaji Muhammad; Oluwatoba Emmanuel Oyeneyin; Nkechi Hope Atasie
    • Citation: Preprint
    • Link: DOI: 10.21203/rs.3.rs-2035291/v1

 

  • Antioxidant-Rich Nutraceutical as a Therapeutic Strategy for Sickle Cell Disease

 

Ildoo Chung | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Ildoo Chung | Pharmacology | Best Researcher Award

Ā Professor, Pusan National University South Korea

Ildoo Chung is a distinguished professor in the Department of Polymer Science and Engineering at Pusan National University, Korea. With a career spanning over two decades, he specializes in polymer chemistry, functional materials, and advanced biomedical engineering applications. Dr. Chung has held prominent academic and administrative positions, including department head and associate dean. He actively contributes to global research through editorial roles, conference leadership, and professional society memberships. Renowned for his dedication to education and innovation, Dr. Chung’s work bridges academia and industry, advancing polymer science worldwide.

Publication Profile

Scopus

Orcid

google scholar

šŸŽ“ Education

Ph.D. in Polymer Science & Engineering, Pusan National University, Korea (2000.08). M.S. in Polymer Science & Engineering, Pusan National University, Korea (1997.02). B.S. in Polymer Science & Engineering, Pusan National University, Korea (1995.02)

šŸ’¼ Experience

Professor, Pusan National University, Korea (2014ā€“present). Associate Dean, College of Engineering, Pusan National University (2018ā€“2020). Department Head, Polymer Science & Engineering, Pusan National University (2013ā€“2017). Visiting Associate Professor, University of Tennessee, USA (2012ā€“2013). Assistant/Associate Professor, Pusan National University (2005ā€“2014). Postdoctoral Fellow, University of Alabama at Birmingham, USA (2000ā€“2002)

šŸ† Awards & Honors

Member, Board of Directors, The Polymer Society of Korea. Editorial roles in Journal of Adhesion and Interface, IJMSE, and others. Numerous conference chair and committee memberships globally. Reviewer for high-impact journals like Macromolecular Research and Dental Materials. Recipient of national and international recognition for polymer research

šŸ”¬ Research Focus

Development of functional polymers for drug delivery and biomedical applications. Advanced polymer composites and their industrial applications. Interface engineering in polymer systems for sustainability. Nanostructured materials and their multifunctional properties. Polymer chemistry for healthcare innovations

Conclusion

Professor Ildoo Chungā€™s academic and professional journey reflects a commitment to advancing knowledge in polymer science and materials engineering. His leadership, research, and editorial work have significantly impacted the field, making him a deserving candidate for the Best Researcher Award. With continued efforts in interdisciplinary collaboration and practical applications, he has the potential to further elevate his influence and contributions to global scientific advancements.

Publication Top Notes

  • Title: L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
    Year: 2024
    Authors: Seoeun Oh, Soo-Yong Park, Hyung Il Seo, Ildoo Chung
    Citation: DOI: 10.3390/pharmaceutics17010028

 

  • Title: Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44
    Year: 2024
    Authors: Vo Van Giau, Giau Van Vo, Van-Giau Vo, Ildoo Chung, Chang-Sik Ha, Seong An, Yang H. Yun
    Citation: DOI: 10.3390/pharmaceutics16060836

 

  • Title: Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine
    Year: 2023
    Authors: Sivagangi Reddy Nagella, Soojeong Choi, Soo-Yong Park, Chang-Sik Ha, Youngmi Jung, Ramesh Kumar Chitumalla, Joonkyung, Ji-Young Yoon, Ildoo Chung
    Citation: DOI: 10.3390/ijms242216470

 

  • Title: Effects of Recycled Polymer on Melt Viscosity and Crystallization Temperature of Polyester Elastomer Blends
    Year: 2023
    Authors: Ji-Eun Lee, Jin-Woo Lee, Jae-Wang Ko, Kyung-Il Jo, Hyun-Ju Park, Ildoo Chung
    Citation: DOI: 10.3390/ma16176067

 

  • Title: Carboxymethyl cellulose/montmorillonite bionanocomposite films incorporated with polyhedral oligomeric silsesquioxane
    Year: 2022
    Authors: Jin H., Yan Y.-Z., Lee C.S., Lee J.-H., Chung I., Ha C.-S.
    Citation: DOI: 10.1080/09276440.2022.2151262

 

  • Title: Effect of the Surface Modification of Silica Nanoparticles on the Viscosity and Mechanical Properties of Silica/Epoxy Nanocomposites
    Year: 2022
    Authors: Kim T., Kwon S.-H., Kim H.J., Lim C.-S., Chung I., Lee W.-K., Seo B.
    Citation: DOI: 10.1080/09276440.2022.2094572

 

  • Title: Polydopamine/Polypyrrole Modified Graphite Felt Enhances Biocompatibility for Electroactive Bacteria and Power Density of Microbial Fuel Cell
    Year: 2022
    Authors: Kim M., Li S., Kong D.S., Song Y.E., Park S.-Y., Kim H.-I., Jae J., Chung I., Kim J.R.
    Citation: EID: 2-s2.0-85133636105

 

  • Title: Polyol and Polyurethane Containing Bisphenol-Z: Synthesis and Application for Toughening Epoxy
    Year: 2022
    Authors: Lee D.Y., Kim H.J., Kim H.-G., Lim C.-S., Chung I., Seo B.
    Citation: DOI: 10.1002/app.53013

 

  • Title: ROS- and pH-Responsive Polydopamine Functionalized Tiā‚ƒCā‚‚Tā‚“ MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Veena Vijayan, Lee Jun Seok, Sung Soo Park, Xiuguo Cui, Ildoo Chung, Jaejun Lee, Suk-kyun Ahn, Jung Rae Kim, et al.
    Citation: DOI: 10.3390/nano12244392

 

  • Title: Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Yong-Zhu Yan, Sung Soo Park, Anandhu Mohan, Ildoo Chung, Suk-kyun Ahn, Jung Rae Kim, Chang-Sik Ha
    Citation: DOI: 10.3390/ijms232314925

 

 

Daniela Malengo | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Dr. Daniela Malengo | Pharmacology | Women Researcher Award

Dr at Istituto Europeo di Oncologia, Italy

Daniela Malengo, an Italian pharmacist, is currently the Vice Director of the Hospital Pharmacy Division at Istituto Europeo di Oncologia, Milan. With a career spanning over 15 years, Daniela specializes in oncology drug management, hospital pharmacy administration, and medical device protocols. She is passionate about optimizing pharmaceutical practices and contributing to oncology care. Throughout her career, she has been dedicated to ensuring the safe and effective use of drugs in oncological treatments and has supported numerous research projects. Her leadership skills also extend to teaching pharmacy students through internships and projects.

Profile

Scopus

šŸŽ“ EducationĀ 

Management of CAR-T Patients, LIUC Business School (Dec 2023ā€“Mar 2024). Hospital Pharmacy Management, UniversitĆ  Bocconi, Milan (Sept 2019ā€“Dec 2020). Specialization in Applied Pharmacology, University of Pavia (2005ā€“2009). Degree in Pharmacy, University of Pavia (2000ā€“2005). State Exam for Pharmacist License, University of Pavia (Novā€“Dec 2005). Scientific High School Diploma, Liceo Scientifico N. Copernico, Pavia (1995ā€“2000)

šŸ’¼ Experience

Vice Director of Hospital Pharmacy Division, Istituto Europeo di Oncologia, Milan (July 2023ā€“Present): Managing narcotic drug dispensation and overseeing oncological therapy. Assistant Pharmacist, Istituto Europeo di Oncologia, Milan (Mar 2011ā€“July 2023): Managed medical devices and chemotherapy prescriptions. Pharmacist ā€“ Research Fellow, Istituto Europeo di Oncologia, Milan (May 2006ā€“Feb 2011): Supervised experimental drugs and contributed to research on oncological drug appropriateness. Intern (2004ā€“2005): Worked at Farmacia Dott. A. Lodola, Siziano, dispensing medications to the public.

šŸ† Awards & Honors

Numerous presentations at national congresses, including SIFO Congress (2009ā€“2010). Recognized for contributions to hospital pharmacy management and cost analysis of oncological treatments. Leadership roles in pharmacy student internships and research programs. Awarded for excellence in promoting safe oncological drug usage.

šŸ”¬ Research Focus

Oncology Pharmacology: Focuses on managing oncological drug appropriateness, chemotherapy prescriptions, and medical device protocols. Pharmacy Management: Expertise in hospital pharmacy operations, including drug dispensation, quality control, and patient safety. Experimental Pharmacology: Managed experimental drugs and contributed to clinical research in oncological treatments. Cost Analysis: Focus on managing hospital pharmacy expenses and evaluating drug cost-effectiveness.

Conclusion

Daniela Malengo’s career exemplifies dedication to hospital pharmacy, oncological drug management, and the advancement of healthcare systems through her research and leadership roles. Her consistent contributions to improving patient outcomes in oncology, coupled with her academic excellence, make her a strong candidate for the Women Researcher Award. With her continued focus on improving the quality of healthcare services and mentoring future professionals, Danielaā€™s future contributions are poised to have a lasting impact in both the pharmacy and healthcare sectors.

šŸ“šPublicationsĀ 

  • The Prolonged Clinical Benefit with Metronomic Chemotherapy (VEX Regimen) in Metastatic Breast Cancer Patients
    • Authors: Montagna, E., Pagan, E., Cancello, G., Viale, G., Colleoni, M.
    • Journal: Anti-Cancer Drugs
    • Volume: 33
    • Issue: 1
    • Pages: E628ā€“E634
    • Year: 2022
    • Citations: 6

 

  • Management of Breast Cancer Patients During the Peak of the COVID-19 Pandemic
    • Authors: Montagna, E., Bellerba, F., Sangalli, C., Colleoni, M., Veronesi, P.
    • Journal: European Journal of Surgical Oncology
    • Volume: 47
    • Issue: 10
    • Pages: 2694ā€“2695
    • Year: 2021
    • Citations: 2

 

Srijan Acharya | Molecular Pharmacology | Excellence in Research

Posted on by ScienceFather

Dr. Srijan Acharya | Molecular Pharmacology | Excellence in Research

Dr at St. Jude Children’s Research Hospital, United States

Srijan Acharya is a dedicated scientist with expertise in molecular pharmacology and cancer genomics. He is currently a Post-Doctoral Research Fellow at St. Jude Childrenā€™s Research Hospital, focusing on childhood cancer research. With 32 published scientific articles and a total citation count of over 385, his work has contributed significantly to biomarker discovery, receptor pharmacology, and immuno-oncology. His research aims to address therapeutic resistance in pediatric malignancies through small molecule screening. Srijan is fluent in English, Bangla, and Hindi, with basic knowledge of Korean.

Profile

Scholar

šŸŽ“ Education

PhD in Molecular Pharmacology from Chonnam National University, South Korea (2020). M.Sc. in Biotechnology from North South University, Bangladesh (2015). BPHRM in Pharmacy from East West University, Bangladesh (2012). His academic journey has provided a strong foundation in receptor pharmacology and molecular biology, guiding his transition into cancer research.

šŸ’¼ Experience

Post-Doctoral Research Fellow, Pharmacy Department, St. Jude Childrenā€™s Research Hospital, USA (2023-Present). Post-Doctoral Research Fellow, Pathology Department, Mitchell Cancer Institute, USA (2020-2023). Executive Officer, Research and Development, Square Pharmaceutical PLC, Bangladesh (2012-2013). His experience spans academia and industry, with a focus on cancer research, receptor signaling, and small molecule screening.

šŸ† Awards and Honors

Inducted into Sigma Xi, The Scientific Research Honor Society (2023). Recognized in Whoā€™s Who in America by Marquis (2023). Young Investigator Award at AACR conference by AAISCR (2022). Best Presenter Award from China Pharmaceutical University (2021). Global Scholarship from Chonnam National University, Korea (2015). These accolades reflect his significant contributions to molecular pharmacology and cancer research.

šŸ”¬ Research Focus

Srijanā€™s research primarily investigates the role of molecular signaling in cancer, focusing on the interaction of nicotine receptors with GPCRs and their impact on cancer progression. At St. Jude, his work focuses on childhood cancers, particularly Ewing sarcoma and rhabdomyosarcoma. He uses small molecule screening to discover potential therapeutic agents and aims to overcome therapeutic resistance in pediatric cancers.

Conclusion

Srijan Acharya is a highly accomplished and promising researcher whose contributions to cancer pharmacology and molecular biology are noteworthy. His interdisciplinary research approach, combined with his dedication to advancing pediatric oncology, positions him as a leader in the field. With continued mentorship and broader collaborative efforts, Acharya is well poised for even greater achievements, further solidifying his place as an influential scientist in the biomedical community.

šŸ“šPublicationsĀ 

  • Title: Unveiling the intracellular dynamics of Ī±4Ī²2 nAChR-mediated ERK activation through the interplay of arrestin, GĪ²Ī³, and PKCĪ²II
    Year: 2024
    Authors: Dooti K, Acharya S, Wang S, Kim K.M.

 

  • Title: Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer
    Year: 2023
    Authors: Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP

 

  • Title: MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer
    Year: 2023
    Authors: Md Khan, S Acharya, S Anand, F Sameeta, P Pramanik, C Keel, S Singh, James E Carter, S Dasgupta, A Singh

 

  • Title: Comparative study of the molecular mechanisms underlying the G protein and Ī²-arrestin-dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptor
    Year: 2023
    Authors: Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, Li H, Zhang X

 

  • Title: Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis
    Year: 2023
    Authors: Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S.

 

  • Title: Nicotine causes alternative polarization of macrophages via Src-mediated STAT3 activation: Potential pathobiological implications
    Year: 2022
    Authors: Acharya S, Saranyutanon S, Deshmukh SK, Khan MA, Singh S, Singh AP

 

  • Title: Ī²-Arrestin1 and GRK2 play permissive roles in Src-mediated endocytosis of Ī±4Ī²2 nicotinic acetylcholine receptor
    Year: 2021
    Authors: Acharya S, Kundu D, Kim KM

 

  • Title: Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
    Year: 2021
    Authors: Acharya S, Kim KM

 

  • Title: Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer
    Year: 2021
    Authors: Miree, O., Srivastava, ā€¦Acharya S.et al.

 

  • Title: Metabotropic signaling cascade involved in Ī±4Ī²2 nicotinic acetylcholine receptor-mediated PKCĪ²II activation
    Year: 2020
    Authors: Acharya S, D. Kundu, H.J. Choi, and K.M. Kim

 

  • Title: Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation
    Year: 2019
    Authors: Acharya S, Kim M., Botanas C. J., Custodio R. J., Lee H. J., Sayson L. V., Kim H. J.

 

  • Title: Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors
    Year: 2017
    Authors: Paudel S, Acharya S, Yoon G, Kim K.M., & Cheon S.H.

 

Sara Uldry JĆŗlio | Neurophysiology and Pain Research| Best Researcher Award

Posted on by ScienceFather

Dr. Sara Uldry JĆŗlio | Neurophysiology and Pain Research| Best Researcher Award

Ā Dr at Spinal Cord Injury Center, Balgrist University Hospital, University of Zurich, Zurich, SwitzerlandĀ 

Dr. Sara Uldry JĆŗlio is a postdoctoral researcher at the Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland. With dual citizenship in Switzerland and Portugal, she completed her Ph.D. in Neuroscience in 2024, focusing on the physiology and pathophysiology of intra-epidermal evoked potentials. Her research contributes to spinal cord injury recovery, blending her technical expertise with clinical applications. Beyond research, Dr. JĆŗlio has been an active medical technical assistant and has mentored students and interns. She is passionate about neurophysiology and has a strong record of international collaborations and scientific publications.

Profile

Scopus

šŸŽ“ Education

Dr. JĆŗlio earned her Ph.D. in Neuroscience from the University of Zurich in 2024, researching intra-epidermal electrically evoked potentials. Before that, she completed a Master of Science in Biology, with a major in Neuroscience from ETH Zurich, Switzerland (2019), and conducted research in various renowned institutions like the City College of New York and Champalimaud Centre for the Unknown in Lisbon. She holds a Bachelor of Science in Biology from ETH Zurich (2017) and graduated with an Abitur from the German School of Lisbon, Portugal (2013).

šŸ’¼ Experience

Dr. JĆŗlio has been a postdoctoral researcher at the Spinal Cord Injury Center since February 2024, continuing her groundbreaking research in spinal cord injury neurophysiology. She also worked as a medical technical assistant in the Neurophysiology department at Balgrist University Hospital since August 2020. Dr. JĆŗlio’s early experience includes research assistant positions at the Institute of Molecular Systems Biology at ETH Zurich, the Spinal Cord Injury Center, and IES Ltd. She has participated in diverse research projects across Switzerland, Portugal, and the USA.

šŸ† Awards and Honors

Dr. JĆŗlio was awarded the University of Zurich Candoc Grant (2022-2023), which funded her Ph.D. research with 57,546 CHF. She has co-authored several peer-reviewed publications and presented her work at prestigious international conferences, such as the European Pain Federation and the Zurich Neuroscience Center. Her research on intra-epidermal electrically evoked potentials has been widely recognized for its potential clinical applications in spinal disorders. Additionally, Dr. JĆŗlio has supervised masterā€™s students and interns, contributing significantly to academic leadership.

šŸ”¬ Research Focus

Dr. JĆŗlioā€™s research is centered on neurophysiology, particularly intra-epidermal electrically evoked potentials and their application in spinal cord injury diagnostics and treatments. Her work investigates the nociceptive specificity and clinical applicability of these potentials in conditions like degenerative cervical myelopathy. Dr. JĆŗlio’s interdisciplinary studies also include the neurophysiological underpinnings of pain perception and student attentional engagement using eye tracking and brain activity. She aims to bridge basic research with clinical applications in spinal cord disorders.

šŸ“œ Conclusion

Dr. Sara Uldry JĆŗlio is a promising and accomplished researcher, whose work in neuroscience and spinal cord injury research has already garnered significant recognition. Her leadership, mentorship, and successful publication record make her an excellent candidate for the Best Researcher Award, especially in the field of neurophysiology. Continued expansion of her independent research projects and teaching portfolio could further solidify her reputation as a leading scientist in the field.

Publications Top Notes

  • Intra-epidermal electrically evoked potentials are sensitive to detect degenerative cervical myelopathy suggesting their spinothalamic propagation
    Authors: JĆŗlio, S.U., Schneuwly, M., Scheuren, P.S., Hubli, M., Schubert, M.
    Journal: Clinical Neurophysiology
    Year: 2024
    Cited by: 0

 

  • Intra-epidermal evoked potentials: A promising tool for spinal disorders?
    Authors: LĆ¼tolf, R., JĆŗlio, S.U., Schubert, M., Hubli, M.
    Journal: Neurophysiologie Clinique
    Year: 2022
    Cited by: 4

 

Faiyaz Shakeel |Pharmaceutical sciences | Best Researcher Award

Posted on by ScienceFather

Ā Prof Dr. Faiyaz Shakeel | Pharmaceutical sciences |Best Researcher Award

Prof Dr. King Saud University, Saudi Arabia

šŸ‘©ā€šŸ”¬Highly accomplished in pharmaceutics, holds a Ph.D. and M. Pharm. from Jamia Hamdard University, India. With extensive experience as a Professor and Associate Professor at King Saud University, Riyadh, Saudi Arabia, and previous roles in academia and research, he excels in formulation research and development. His expertise spans nanoemulsions and transdermal dosage forms, contributing significantly to the field. Driven by a passion for innovation, he led groundbreaking projects, optimizing drug delivery systems for enhanced therapeutic outcomes. Eager to leverage his skills and knowledge, he seeks to join a renowned research organization, fostering growth and advancement in pharmaceutical sciences.šŸŒŸ

 

Profile

 

Scholar

 

šŸŽ“ Ā Objectives

Seeking association with a renowned research organization in formulation research and development to upgrade knowledge, research, and management skills in line with the latest trends. Eager to be part of a dynamic team contributing to organizational growth.

šŸ“š Ā Qualification Overview

Doctor of Philosophy (Ph.D.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2004-2007. Master of Pharmacy (M. Pharm.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2002-2004. Bachelor of Pharmacy (B. Pharm.), Jamia Hamdard University, New Delhi, India, 1998-2002.

šŸ‘Øā€šŸ« Professional Experience

Professor, King Saud University, Riyadh, Saudi Arabia (Feb 2022 – Present) Associate Professor, King Saud University, Riyadh, Saudi Arabia (Mar 2016 – Feb 2022) Assistant Professor, King Saud University, Riyadh, Saudi Arabia (Nov 2011 – Mar 2016) Lecturer, Garyounis University, Benghazi, Libya (Nov 2007 – Nov 2011) Senior Lecturer, Bhawani Shankar Anangpuria Institute of Pharmacy, Faridabad, India (Aug 2006 – Oct 2007) Guest Lecturer, Shri Gopichand College of Pharmacy, Baghpat, India (Jul 2004 – Jun 2006)

šŸ… Ā Professional Qualification

Ph.D. Title: Formulation and development of transdermal dosage form (Nanoemulsions) for antirheumatoid drug, Jamia Hamdard University, New Delhi, India, 2004-2007. M. Pharm. Title: Development and evaluation of bioadhesive transdermal gels of diclofenac diethylamine, Jamia Hamdard University, New Delhi, India, 2002-2004. B. Pharm., Jamia Hamdard University, New Delhi, India, 1998-2002.

šŸ”¬Ā Practical Experience

Master’s Research Project: Developed bioadhesive transdermal gels for diclofenac diethylamine. Ph.D. Thesis: Developed nanoemulsion and nanoemulsion gel formulations of celecoxib and aceclofenac for arthritis.

šŸ”Conclusion of Research Projects

Master’s Project: Optimized gel showed controlled drug release and significant anti-inflammatory effects. Ph.D. Thesis: Developed nanoemulsion formulations with controlled release, higher absorption, and significant pharmacodynamic effects.

Publications Top Notes šŸ“

  • Development and bioavailability assessment of ramipril nanoemulsion formulation
    • Authors: S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
    • Journal: European journal of pharmaceutics and biopharmaceutics
    • Year: 2007
    • Volume: 66
    • Issue: 2
    • Pages: 227-243
    • Citations: 1006

 

  • Nanoemulsions as vehicles for transdermal delivery of aceclofenac
    • Authors: F Shakeel, S Baboota, A Ahuja, J Ali, M Aqil, S Shafiq
    • Journal: Aaps Pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: 191-199
    • Citations: 427

 

  • Formulation development and optimization using nanoemulsion technique: a technical note
    • Authors: S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, …
    • Journal: AAPS pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: E12-E17
    • Citations: 420

 

  • Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib
    • Authors: S Baboota, F Shakeel, A Ahuja, J Ali, S Shafiq
    • Journal: Acta pharmaceutica
    • Year: 2007
    • Volume: 57
    • Issue: 3
    • Pages: 315-332
    • Citations: 397

 

  • A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
    • Authors: A Muheem, F Shakeel, MA Jahangir, M Anwar, N Mallick, GK Jain, …
    • Journal: Saudi Pharmaceutical Journal
    • Year: 2016
    • Volume: 24
    • Issue: 4
    • Pages: 413-428
    • Citations: 384